17 spine devices receive FDA clearance in December

The FDA granted clearance of 17 spine devices in December.

Advertisement

1. Posterior Fusion Plate, HA Posterior Fusion Plate from Spinal Simplicity

2. Tailored-C Cervical Interbody Fusion System from BeSpoke Technologies

3. Lucero Medical Cervical Cage System from Lucero Medical

4. NuVasive Navigation.S Instruments from NuVasive

5. LnK MIS Spinal System, PathLoc-L MIS Spinal System, AccelFix-MIS Spinal System from L&K Biomed.

6. Impulse Interbody Fusion System from DeGen Medical

7. ChoiceSpine Tiger Shark Cervical Spacer System from ChoiceSpine

8. WaveForm L Interbody System from SeaSpine Orthopedics

9. Aprevo Intervertebral Body Fusion Device from Carlsmed

10. Nexxt Matrixx Stand Alone ALIF System from Nexxt Spine

11. Lucent XP, Lucent XP Curved from Spinal Elements

12. OmniTom Elite from NeuroLogica

13. IdentiTi Cervical Standalone Interbody System from Alphatec Spine

14. Invictus OCT Spinal Fixation System from Alphatec Spine

15. ARx Iliac Spinal Screw System from Life Spine

16. NuVasive ACP System from NuVasive

17. LineSider Spinal System from Integrity Implants

More articles on devices:
Medtronic CEO predicts AI, machine learning as ‘the new frontier for medtech’ — 4 key quotes
40 orthopedic devices receiving FDA clearance in December
Stryker, Smith+Nephew seal 1st acquisitions of 2021: 7 device company notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.